Figure 1From: Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of lifeDistribution of change in AQLQ overall score at (a) 28 weeks and (b) 52 weeks. AQLQ = Asthma Quality of Life Questionnaire; FOR/BUD = formoterol/budesonide combination; SAL/FP = salmeterol/fluticasone propionate combination.Back to article page